Article Details

Hansa Biopharma Appoints Donato Spota as New Chief Financial Officer

Retrieved on: 2019-02-06 15:30:00

Tags for this article:

Click the tags to see associated articles and topics

Hansa Biopharma Appoints Donato Spota as New Chief Financial Officer. View article details on hiswai:

Excerpt

<div>LUND, Sweden, Feb. 7, 2019 /PRNewswire/ -- Hansa Biopharma AB, the leader in immunomodulatory enzyme technology for rare IgG-mediated ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo